Neurofeedback Training of Alpha-band Coherence After Stroke

October 27, 2016 updated by: Adrian Guggisberg, University Hospital, Geneva

Neurofeedback Training of Alpha-band Coherence After Stroke: a Randomized Controlled Crossover Trial

Background: The technology of brain-computer interfaces (BCI) enables the monitoring of brain activity and the generation of a real-time output about specific changes in activity patterns. The recorded subject receives a feedback about the neural activity associated his/her efforts and can thus learn to voluntarily modulate brain activity. There is accumulating evidence that training of motor cortex activations with brain-computer interface systems can enhance recovery in stroke patients. Here we propose a new approach which trains resting-state correlates of motor performance instead of activations related to movements. Previous studies have shown that the more resting-state alpha oscillations in the motor cortex are coherent with the rest of the brain, the better stroke patients perform in motor tasks. Furthermore, observational studies have suggested that training of alpha-band coherence in the motor cortex with neurofeedback has beneficial effects on motor performance.

Objective : This randomized controlled study aims to test the usefulness of training functional connectivity between the motor cortex and the rest of the brain with a brain-computer interface in patients with chronic stroke. We hypothesized that this network variant of neurofeedback training will lead to region and frequency specific increases in functional connectivity and to an improved function of the affected upper extremity.

Methods : 10 patients with chronic stroke and significant unilateral deficit of upper extremity motor function will perform two periods of neurofeedback training in a randomized cross-over design. In one period, they will train alpha-band coherence between intact areas around the affected motor cortex and the rest of the brain. In a control period, they will train alpha-band coherence between a control region not directly related to motor function (the medial prefrontal cortex of the healthy hemisphere) and the rest of the brain. In each period, two training sessions per week will be performed for 4 weeks. The periods are separated by at least 4 weeks. Oscillations in the brain will be reconstructed from 128 EEG channels using an adaptive spatial filter and the coherence between the target area and the rest of the brain will be calculated in real time. Coherence magnitude will be displayed in the form of a cursor on a computer screen.

Significance: This study may provide causal evidence for a role of functional connectivity in motor learning and may lead to new strategies for rehabilitation.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • GE
      • Geneva, GE, Switzerland, 1211
        • Division of Neurorehabilitation, University Hospital of Geneva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ischemic or hemorrhagic stroke in chronic stage (at least 9 months after onset)
  • unilateral deficits in motor function with significant impact on independence and daily activities

Exclusion Criteria:

  • inability to participate in long treatment sessions
  • inability to concentrate for prolonged periods
  • metallic objects in the brain
  • presence of implants or neural stimulators
  • persistent delirium or disturbed vigilance
  • moderate or severe language comprehension deficits
  • skull breach
  • new stroke lesions during treatment
  • medical complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Motor Cortex
Feedback training of functional connectivity between motor cortex and the rest of the brain
Placebo Comparator: Control region
Feedback training of functional connectivity between medial prefrontal cortex of healthy hemisphere and the rest of the brain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl Meyer Upper Extremity Motor Assessment Score
Time Frame: Week 4
Change in Fugl Meyer Upper Extremity Motor Assessment Score from before to after treatment.
Week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl Meyer Upper Extremity Motor Assessment Score at 1 month follow up
Time Frame: 8 weeks
Change in Fugl Meyer Upper Extremity Motor Assessment Score from before treatment to 1 month after treatment.
8 weeks
Change in compound motor score
Time Frame: 4 weeks
For calculation of the compound motor score, the Fugl Meyer Upper Extremity Motor Assessment, the Nine Hole Peg test, and the Jamar Dynamometer assessment are each normalized to values and then averaged. Change is computed as difference from before treatment to after treatment.
4 weeks
Change in compound motor score at follow up
Time Frame: 8 weeks
For calculation of the compound motor score, the Fugl Meyer Upper Extremity Motor Assessment, the Nine Hole Peg test, and the Jamar Dynamometer assessment are each normalized to values and then averaged. Change is computed as difference from before treatment to 4 weeks after treatment.
8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Nine Hole Peg test
Time Frame: 4 weeks
Change in Nine Hole Peg test from before treatment to after treatment.
4 weeks
Change in Nine Hole Peg test at follow up
Time Frame: 8 weeks
Change in Nine Hole Peg test from before treatment to 4 weeks after treatment.
8 weeks
Change in Motor Activity Log
Time Frame: 4 weeks
The Motor Activity Log assessed changes in motor activities of daily living. Change in Nine Hole Peg test from before treatment to after treatment.
4 weeks
Change in Nine Hole Peg at follow up
Time Frame: 8 weeks
The Motor Activity Log assessed changes in motor activities of daily living. Change in Nine Hole Peg test from before treatment to 4 weeks after treatment.
8 weeks
Change in Spasticity
Time Frame: 4 weeks
Change in Modified Ashworth Score from before treatment to after treatment.
4 weeks
Change in Spasticity at follow up
Time Frame: 8 weeks
Change in Modified Ashworth Score from before treatment to 4 weeks after treatment.
8 weeks
Change in Medical Research Council (MRC) muscle strength
Time Frame: 4 weeks
Change in Medical Research Council (MRC) muscle strength from before treatment to after treatment.
4 weeks
Change in Medical Research Council (MRC) muscle strength at follow up
Time Frame: 8 weeks
Change in Medical Research Council (MRC) muscle strength from before treatment to 4 weeks after treatment.
8 weeks
Change in European Stroke Scale
Time Frame: 4 weeks
Change in Change in European Stroke Scale from before to after treatment.
4 weeks
Change in Change in European Stroke Scale at follow up
Time Frame: 8 weeks
Change in Change in European Stroke Scale from before to 4 weeks after treatment.
8 weeks
Change in walking speed
Time Frame: 4 weeks
Change in walking speed as measured with 10m walking test from before to after treatment.
4 weeks
Change in walking speed at follow up
Time Frame: 8 weeks
Change in walking speed as measured with 10m walking test from before to 4 weeks after treatment.
8 weeks
Change in timed up and go (TUG) test
Time Frame: 4 weeks
Change in timed up and go (TUG) test from before to after treatment.
4 weeks
Change in timed up and go (TUG) test at follow up
Time Frame: 8 weeks
Change in timed up and go (TUG) test from before to 4 weeks after treatment.
8 weeks
Change in tactile sensibility
Time Frame: 4 weeks
Change in tactile sensibility measured with standardized filaments from before to after treatment.
4 weeks
Change in tactile sensibility at follow up
Time Frame: 8 weeks
Change in tactile sensibility measured with standardized filaments from before to 4 weeks after treatment.
8 weeks
Number of Adverse Events
Time Frame: 4 weeks
4 weeks
Number of Adverse Events at follow up
Time Frame: 8 weeks
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adrian G Guggisberg, MD, University of Geneva

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

August 21, 2014

First Submitted That Met QC Criteria

August 21, 2014

First Posted (Estimate)

August 22, 2014

Study Record Updates

Last Update Posted (Estimate)

October 31, 2016

Last Update Submitted That Met QC Criteria

October 27, 2016

Last Verified

October 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Neurofeedback training of functional connectivity

3
Subscribe